Market Research Logo

Global Artificial Pancreas Devices System Market 2016-2020

Global Artificial Pancreas Devices System Market 2016-2020

About Artificial Pancreas Devices System

Artificial organs are human-made bioartificial devices, which are implanted or integrated into individuals to replace or support natural organs. These include artificial heart, kidney, pancreas, and cochlear implants. Biocompatible materials such as polymers (polyurethane, polysulfone, and porous polypropylene), biologics, ceramics, and metals are used to develop artificial organs. These organs are incorporated with different technologies like sensors, biomaterials, and innovative delivery systems. Artificial organs perform the function of the natural organ and help the patient to live a quality life. In few cases, artificial organs are capable of eliminating the need for organ transplantation altogether.

Technavio’s analysts forecast the global artificial pancreas devices system market to grow at a CAGR of 7.40% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global artificial pancreas devices system market for 2016-2020. To calculate the market size, the report considers the revenue generated from sales of the different products.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Artificial Pancreas Devices System Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Medtronic
  • Johnson & Johnson
  • Insulet
  • Tandem Diabetes Care
  • Roche
Other prominent vendors
  • Beta Bionics
  • Bigfoot Biomedical
  • Cellnovo
  • Dexcom
  • Dose Safety
  • DreaMed Diabetes
  • Inreda Diabetic
  • Type Zero Technologies
Market driver
  • Growing technological integration fueling the market growth.
  • For a full, detailed list, view our report
Market challenge
  • Lack of smart control algorithms affecting the adoption rate of existing APDS.
  • For a full, detailed list, view our report
Market trend
  • Growing demand for remote monitoring application.
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Artificial Pancreas Devices System Market 2016-2020

Technavio recognizes the following companies as the key players in the global artificial pancreas devices system market: Medtronic, Johnson & Johnson, Insulet, Tandem Diabetes Care, and Roche.

Other Prominent Vendors in the market are: Beta Bionics, Bigfoot Biomedical, Cellnovo, Dexcom, Dose Safety, DreaMed Diabetes, Inreda Diabetic, and Type Zero Technologies.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing focus on closed loop systems. The increasing demand for APDS has driven the vendors to undertake extensive clinical trials toward product improvement, which are expected to have a positive impact on the market growth. The vendors such as Medtronic, Tandem Diabetes Care, Johnson & Johnson, and Insulet are currently focusing on the development of closed loop APDS, which is expected to propel the market growth owing to its potential advantages compared with existing APDS. The existing open loop APDS are low glucose suspend devices with semi-automation. As these systems are not integrated with advanced algorithms, the required user intervention is at a moderate level. On the contrary, closed-loop APDS are externally worn medical devices, which would enable individuals with type 1 diabetes to regulate blood glucose levels in a fully automated way with zero intervention required from the user.”

According to the report, one driver in the market is increasing initiatives of research organizations fostering innovation in the market. The inspiring initiatives of research organizations such as JDRF enable the development of innovative products in the market. JDRF launched Artificial Pancreas Project in 2006 to foster the development of an artificial pancreas to help individuals with diabetes. Subsequently, JDRF collaborated with Medtronic in 2014 to develop a novel redundant sensor system, which is designed to boost the accuracy and reliability of APDS. The research also focused on the development of orthogonally redundant sensor system, which integrates an electrochemical sensor along with an optical sensor to provide accurate glucose values. Earlier, in June 2013, JDRF collaborated with BD for a three-year time period to develop a single optimized device that will handle multiple functions and avoid the need and complexities of dwelling catheters. Recently, the researchers at Harvard University started a program to identify and develop an effective treatment for type 1 diabetes. Subsequently, National Institutes of Health awarded $12.5 million to Harvard University in 2016 to undertake the field testing of two artificial pancreas algorithms. Such initiatives lead to the development of novel products as well as upgradation of existing systems.

Further, the report states that one challenge in the market is lack of smart control algorithms affecting the adoption rate of existing APDS. Though there are important developments in sensor and pump technology, the APDS is associated with the delays and inaccuracies in glucose sensing and insulin delivery. Such type of issues occurs when there is a disturbance in the routine system (such as uptake of meal), which triggers a rapid glucose rise that is significantly faster than the time required for insulin absorption and action. Thus, the vendors should focus on designing an APDS with smart sensors that consider a relatively slow response, giving time for the delays to fade before the next control action. In particular, to avoid hypoglycemia after a meal, the vendors has to design a moderately aggressive controller. This has driven the vendors to research on new control design, model predictive control (MPC) algorithm, which is based on a prediction of glucose dynamics using a model of the individual's metabolic system. According to clinical studies, this design may be better for mitigation of time delays due to subcutaneous glucose sensing and insulin infusion. However, such smart algorithms have limited clinical evidence, and it may take few more years to develop an ideal algorithm.



Companies Mentioned

Medtronic, Johnson & Johnson, Insulet, Tandem Diabetes Care, Roche, Beta Bionics, Bigfoot Biomedical, Cellnovo, Dexcom, Dose Safety, DreaMed Diabetes, Inreda Diabetic, Type Zero Technologies.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Assumptions
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
    • A glance at parent market: Artificial organs
      • Table Key segments in artificial organ market
  • An overview of pancreas and diabetes
    • Pancreas
    • Diabetes
      • Table Diagnosis of diabetes by blood sugar test
      • Table Diagnosis of diabetes by glycated hemoglobin test
      • Table Treatment algorithm for type 2 diabetes
    • Insulin overview
  • Need for better systems in the management of diabetes
    • Table Factors that fuelled the need for APDS
  • Artificial pancreas device system
    • Technology landscape
      • Table Technology involved in the functioning of APDS
      • Table Barriers in CGM
      • Table Barriers in hormonal pumps
      • Table Key findings of researchers related to algorithms till date
  • Initiatives for the development of APDS
    • Juvenile Diabetes Research Foundation (JDRF) initiative - 2006
    • European Commission's AP@home project - 2010
    • Centre for bio-inspired technology - Bionic pancreas
    • Harvard University - 2014
  • FDA's role in fostering the development of APDS
    • Rapid response to preliminary study plans
    • Interactive review of investigational device exemption study plans
    • Guidance and standards for researchers and industry
  • Reimbursement scenario
    • Australia
    • Germany
    • UK
    • US
  • Key clinical trials
    • Table Key clinical trials
  • Market landscape
    • Market overview
      • Table Global APDS market snapshot
      • Table Development path of APDS
      • Table Global APDS market 2015-2020 ($ millions)
      • Table Key factors driving the demand for closed loop systems
      • Table Scenario analysis of global APDS market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by categories
    • TSDS
    • NTSDS
    • CTRS
      • Table Pipeline products
    • CTTS
      • Table Key pipeline products
      • Table Scenario analysis of key segments in global APDS market
  • Geographical segmentation
    • Table Segmentation of global APDS market based on geography 2015 and 2020
    • Table APDS market revenue by geography 2015-2020 ($ millions)
    • APDS market in Americas
      • Table Market scenario in Americas
      • Table APDS market in the Americas ($ millions)
    • APDS market in EMEA
      • Table Market scenario in EMEA
      • Table APDS market in EMEA ($ millions)
    • APDS market in APAC
      • Table Market scenario in EMEA
      • Table APDS market in APAC ($ millions)
  • Market drivers
    • Growing technological integration fuelling the market growth
      • Table Key technological integrations
    • Increasing initiatives of research organizations fostering innovation in the market
      • Table Key initiatives of research organizations
    • Increasing prevalence of diabetes fuelling the need for effective devices
      • Table Incidence and prevalence for diabetes in the US
      • Table Traditional systems vs APDS
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Lack of smart control algorithms affecting the adoption rate of existing APDS
    • Low penetration rates affecting the market growth
    • Lab-grown pancreatic cell transplant as a potential treatment alternative hindering the growth prospects
      • Table Forcefield analysis of drivers and challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Increasing focus on closed loop systems
      • Table Key trends in the development of closed loop systems
    • Growing demand for remote monitoring applications
      • Table Key products under development for remote monitoring applications
    • Focus of new entrants on the development of novel APDS
      • Table New entrants and their expected product launches
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global APDS market 2015
      • Table Competitive analysis of global APDS market
      • Table Market share analysis 2015
      • Table Market penetration of various APDS manufacturers in global (2015)
      • Table Timeline chart representing the development of APDS
      • Table Strategic success factors of companies in global APDS market
  • Key vendor analysis
    • Medtronic
      • Table Key highlights
      • Table Strength assessment
      • Table Strategy assessment
      • Table Opportunity assessment
    • Johnson & Johnson
      • Table Key highlights
      • Table Strength assessment
      • Table Strategy assessment
      • Table Opportunity assessment
    • Insulet
      • Table Key highlights
      • Table Strength assessment
      • Table Strategy assessment
      • Table Opportunity assessment
    • Tandem Diabetes Care
      • Table Key highlights
      • Table Strength assessment
      • Table Strategy assessment
      • Table Opportunity assessment
    • Roche
      • Table Key highlights
      • Table Strength assessment
      • Table Strategy assessment
      • Table Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report